<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19427829</PMID>
        <DateCompleted>
            <Year>2009</Year>
            <Month>06</Month>
            <Day>19</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2104</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>384</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2009</Year>
                        <Month>Jul</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemical and biophysical research communications</Title>
                <ISOAbbreviation>Biochem Biophys Res Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Motor neuronal protection by L-arginine prolongs survival of mutant SOD1 (G93A) ALS mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>524-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbrc.2009.05.015</ELocationID>
            <Abstract>
                <AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive paralysis due to motor neuron degeneration. Despite the fact that many different therapeutic strategies have been applied to prevent disease progression, no cure or effective therapy is currently available for ALS. We found that L-arginine protects cultured motor neurons from excitotoxic injury. We also found that L-arginine supplementation both prior to and after the onset of motor neuron degeneration in mtSOD1 (G93A) transgenic ALS mice significantly slowed the progression of neuropathology in lumbar spinal cord, delayed onset of motor dysfunction, and prolonged life span. Moreover, L-arginine treatment was associated with preservation of arginase I activity and neuroprotective polyamines in spinal cord motor neurons. Our findings show that L-arginine has potent in vitro and in vivo neuroprotective properties and may be a candidate for therapeutic trials in ALS.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Junghee</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA. junghee@bu.edu</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ryu</LastName>
                    <ForeName>Hoon</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kowall</LastName>
                    <ForeName>Neil W</ForeName>
                    <Initials>NW</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 AG013846</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>NS52724</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS052724</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 NS052724-03</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 AG013846-09</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P30 AG13846</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
                <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2009</Year>
                <Month>05</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Biochem Biophys Res Commun</MedlineTA>
            <NlmUniqueID>0372516</NlmUniqueID>
            <ISSNLinking>0006-291X</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>94ZLA3W45F</RegistryNumber>
                <NameOfSubstance UI="D001120">Arginine</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.15.1.1</RegistryNumber>
                <NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.15.1.1</RegistryNumber>
                <NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.15.1.1</RegistryNumber>
                <NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.3.1</RegistryNumber>
                <NameOfSubstance UI="D001119">Arginase</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>U87FK77H25</RegistryNumber>
                <NameOfSubstance UI="D013095">Spermidine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001119" MajorTopicYN="N">Arginase</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019610" MajorTopicYN="Y">Cytoprotection</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013095" MajorTopicYN="N">Spermidine</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2009</Year>
                <Month>05</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2009</Year>
                <Month>05</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>5</Month>
                <Day>12</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2009</Year>
                <Month>6</Month>
                <Day>20</Day>
                <Hour>9</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19427829</ArticleId>
            <ArticleId IdType="pii">S0006-291X(09)00905-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbrc.2009.05.015</ArticleId>
            <ArticleId IdType="pmc">PMC2744197</ArticleId>
            <ArticleId IdType="mid">NIHMS122547</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2001 May 31;344(22):1688-700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11386269</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10479-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16801544</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2002 Dec;83(5):1030-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12437574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 2003 Apr;53(4):423-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12666108</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Amino Acids. 2003 Jul;25(1):69-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12836061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CNS Drugs. 2003;17(10):699-717</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12873154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuromuscul Disord. 2003 Nov;13(9):737-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14561497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Pharmacother. 2004 Apr;5(4):735-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15102560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Jun 8;101(23):8797-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15169957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 1980;32(4):375-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7358996</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Biochem. 1984;53:749-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6206782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1988 Sep;24(3):446-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2906529</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol. 1991 Jun;260(6 Pt 1):G795-806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2058669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6368-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1648740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 Mar 4;362(6415):59-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8446170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 1993 May 20;363(6426):266-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8487864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Neurol. 1995 Jul;38(1):73-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7611729</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 1996 Jul;17(1):63-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8755479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pathol Biol (Paris). 1996 Jan;44(1):51-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8734301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurosci. 1998 Jun 1;18(11):4083-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9592089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BioDrugs. 2005;19(1):31-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15691215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Neurochem. 2005 Jun;93(5):1087-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15934930</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuron. 2002 Aug 15;35(4):711-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12194870</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
